Mediloq

[Closed for Investment] Mediloq, with a valuation of $5.99 million, is raising funds on StartEngine. The company makes and sells closed-loop child-safe containers for pharmaceutical and supplement manufacturers. The containers of Mediloq are safe and sustainable alternatives to disposable plastic packaging and are durable enough to remain child-safe over a lifetime of reuses and refills. Mediloq has generated significant e-commerce revenue and has signed an agreement with a company to sell its products into over 2,000 B&M stores across the US. Dan Estoque, Nicolas Legare, and Henry Burgess-Marshall founded Mediloq in October 2016. The current crowdfunding campaign has a minimum target of $14,999.73 and a maximum target of $581,202. The campaign proceeds will be used to develop next-gen sustainable child-safe packaging, automated wash and test equipment, and a kiosk collection system, develop partnerships, build a distribution network, and strengthen the patent positions.

Expand

Investment Overview

Raised this Round: Raised: $20,271

Deal Terms

Total Commitments ($USD)

Platform
StartEngine
Start Date
12/05/2022
Close Date
02/03/2023
Min. Goal
$15,000
Max. Goal
$581,202
Min. Investment

$249

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$2.37

Pre-Money Valuation

$5,994,754

Company & Team

Company

Year Founded
2016
Industry
Consumer Products, Goods & Services
Tech Sector
Non-Tech
Distribution Model
B2B/B2C
Margin
Medium
Capital Intensity
Low
Location
Boulder, Colorado
Business Type
Growth
Company Website
Visit Website

Team

Employees
5
Prior Founder Exits?
No
Founder Name
Dan Estoque
Title
CEO
Founder Name
Henry Burgess-Marshall
Title
Director of Marketing
Founder Name
Nick Legare
Title
Director of Business Development

Financials

as of Fiscal Year 2021
 Revenue
$23,733
 Monthly Burn
$1,906
 Runway
0.4 months
Gross Margin
71%

Summary Profit and Loss Statement

FY 2021 FY 2020

Revenue

$23,733

$39,091

COGS

$6,906

$52,211

Tax

$0

$0

 

 

Net Income

$-22,875

$-45,784

Summary Balance Sheet

FY 2021 FY 2020

Cash

$791

$2,981

Accounts Receivable

$0

$0

Total Assets

$791

$55,363

Short-Term Debt

$81,190

$58,724

Long-Term Debt

$0

$126,615

Total Liabilities

$81,190

$185,339

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$36,790
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
02/03/2023 StartEngine $5,994,754 $20,271 Equity - Common Funded RegCF
09/29/2022 Ignite Social Impact $3,125,000 $36,800 Equity - Common Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.

Growth Charts

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Mediloq on StartEngine 2022
Platform: StartEngine
Security Type: Equity - Common
Valuation: $5,994,754
Price per Share: $2.37

Follow company

Follow Mediloq on StartEngine 2022

Buy Mediloq's Deal Report

Warning: according to the close date for this deal, Mediloq may no longer be accepting investments.

Mediloq Deal Report

Get Kingscrowd's comprehensive report on Mediloq including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Mediloq is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Mediloq deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge